Erste Asset Management GmbH Makes New Investment in Omega Healthcare Investors, Inc. (NYSE:OHI)

Erste Asset Management GmbH purchased a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 94,769 shares of the real estate investment trust’s stock, valued at approximately $3,822,000.

A number of other large investors have also made changes to their positions in the stock. Price T Rowe Associates Inc. MD increased its holdings in Omega Healthcare Investors by 2.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 133,166 shares of the real estate investment trust’s stock valued at $4,218,000 after buying an additional 3,466 shares in the last quarter. Tidal Investments LLC increased its stake in Omega Healthcare Investors by 2.5% in the 1st quarter. Tidal Investments LLC now owns 14,325 shares of the real estate investment trust’s stock valued at $454,000 after purchasing an additional 348 shares in the last quarter. Cetera Investment Advisers raised its holdings in Omega Healthcare Investors by 170.6% during the first quarter. Cetera Investment Advisers now owns 97,866 shares of the real estate investment trust’s stock worth $3,099,000 after purchasing an additional 61,700 shares during the last quarter. Cetera Advisors LLC purchased a new stake in Omega Healthcare Investors during the first quarter worth $646,000. Finally, GAMMA Investing LLC grew its holdings in Omega Healthcare Investors by 93.4% in the second quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust’s stock valued at $84,000 after purchasing an additional 1,181 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Insider Transactions at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 10.96 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The trade was a 36.19 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $39.81 on Tuesday. The stock has a fifty day moving average price of $40.59 and a 200 day moving average price of $37.46. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $44.42. The firm has a market capitalization of $10.75 billion, a P/E ratio of 29.27, a PEG ratio of 1.26 and a beta of 0.99. The company has a current ratio of 6.48, a quick ratio of 6.48 and a debt-to-equity ratio of 1.10.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, November 4th. This represents a $2.68 annualized dividend and a dividend yield of 6.73%. Omega Healthcare Investors’s payout ratio is currently 197.06%.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on OHI. Truist Financial lifted their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Berenberg Bank started coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They issued a “buy” rating and a $45.00 price target on the stock. Wells Fargo & Company reissued an “overweight” rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Royal Bank of Canada increased their target price on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th. Finally, BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target for the company in a report on Thursday, October 31st. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $40.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.